Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Larry Gold to Ligands

This is a "connection" page, showing publications Larry Gold has written about Ligands.

 
Connection Strength
 
 
 
0.739
 
  1. Vant-Hull B, Payano-Baez A, Davis RH, Gold L. The mathematics of SELEX against complex targets. J Mol Biol. 1998 May 08; 278(3):579-97.
    View in: PubMed
    Score: 0.132
  2. Irvine D, Tuerk C, Gold L. SELEXION. Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysis. J Mol Biol. 1991 Dec 05; 222(3):739-61.
    View in: PubMed
    Score: 0.085
  3. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15416-21.
    View in: PubMed
    Score: 0.049
  4. Morris KN, Jensen KB, Julin CM, Weil M, Gold L. High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):2902-7.
    View in: PubMed
    Score: 0.033
  5. Gold L, Brown D, He Y, Shtatland T, Singer BS, Wu Y. From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops. Proc Natl Acad Sci U S A. 1997 Jan 07; 94(1):59-64.
    View in: PubMed
    Score: 0.030
  6. Burke DH, Scates L, Andrews K, Gold L. Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. J Mol Biol. 1996 Dec 13; 264(4):650-66.
    View in: PubMed
    Score: 0.030
  7. Brown D, Gold L. RNA replication by Q beta replicase: a working model. Proc Natl Acad Sci U S A. 1996 Oct 15; 93(21):11558-62.
    View in: PubMed
    Score: 0.030
  8. Wecker M, Smith D, Gold L. In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with a small peptide. RNA. 1996 Oct; 2(10):982-94.
    View in: PubMed
    Score: 0.030
  9. He YY, Stockley PG, Gold L. In vitro evolution of the DNA binding sites of Escherichia coli methionine repressor, MetJ. J Mol Biol. 1996 Jan 12; 255(1):55-66.
    View in: PubMed
    Score: 0.028
  10. Drolet DW, Green LS, Gold L, Janjic N. Fit for the Eye: Aptamers in Ocular Disorders. Nucleic Acid Ther. 2016 06; 26(3):127-46.
    View in: PubMed
    Score: 0.028
  11. Chen H, Brown D, Gold L. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases. Methods Enzymol. 1996; 275:503-20.
    View in: PubMed
    Score: 0.028
  12. Jensen KB, Atkinson BL, Willis MC, Koch TH, Gold L. Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci U S A. 1995 Dec 19; 92(26):12220-4.
    View in: PubMed
    Score: 0.028
  13. Binkley J, Allen P, Brown DM, Green L, Tuerk C, Gold L. RNA ligands to human nerve growth factor. Nucleic Acids Res. 1995 Aug 25; 23(16):3198-205.
    View in: PubMed
    Score: 0.027
  14. Allen P, Worland S, Gold L. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. Virology. 1995 Jun 01; 209(2):327-36.
    View in: PubMed
    Score: 0.027
  15. Nieuwlandt D, Wecker M, Gold L. In vitro selection of RNA ligands to substance P. Biochemistry. 1995 Apr 25; 34(16):5651-9.
    View in: PubMed
    Score: 0.027
  16. Ringquist S, Jones T, Snyder EE, Gibson T, Boni I, Gold L. High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. Biochemistry. 1995 Mar 21; 34(11):3640-8.
    View in: PubMed
    Score: 0.027
  17. Chen H, Gold L. Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity. Biochemistry. 1994 Jul 26; 33(29):8746-56.
    View in: PubMed
    Score: 0.025
  18. Schneider D, Tuerk C, Gold L. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J Mol Biol. 1992 Dec 05; 228(3):862-9.
    View in: PubMed
    Score: 0.023
  19. Tuerk C, MacDougal S, Gold L. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci U S A. 1992 Aug 01; 89(15):6988-92.
    View in: PubMed
    Score: 0.022
  20. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 03; 249(4968):505-10.
    View in: PubMed
    Score: 0.019
  21. Chen H, McBroom DG, Zhu YQ, Gold L, North TW. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus. Biochemistry. 1996 May 28; 35(21):6923-30.
    View in: PubMed
    Score: 0.007
  22. Schneider D, Gold L, Platt T. Selective enrichment of RNA species for tight binding to Escherichia coli rho factor. FASEB J. 1993 Jan; 7(1):201-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)